Major Takeda Boost To Japan’s iPSC Ambitions
This article was originally published in PharmAsia News
Executive Summary
If further industry validation were needed of the attractions of Japan's flagship induced pluripotent stem cell (iPSC) technology, it has now been provided in a major practical research collaboration involving the country's largest pharma firm.